PMN
Promis Neurosciences
$11.72
−$0.48 (−3.93%)Jul 27, 2026
Key metrics
The numbers that frame PMN today
- Market cap
- $105.10M
- P/E (TTM)
- -2.6
- EV / FCF
- -1.2
- ROIC
- 761.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $6.27
- 52wk High
- $27.40
Growth
Revenue and earnings trend for PMN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PMN
Is Promis Neurosciences a good buy?
No. Promis Neurosciences has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Promis Neurosciences is selling at a very high price.
What is the market capitalization of PMN?
Promis Neurosciences's market capitalization is $105.10M.
What is the P/E ratio for PMN stock?
Promis Neurosciences's current P/E ratio is -2.6.
What is the 52-week high for PMN stock?
The 52-week high for Promis Neurosciences is $27.40. The current close of $11.72 is 57.2% below that high.
What is the 52-week low for PMN stock?
The 52-week low for Promis Neurosciences is $6.27. The current close of $11.72 is 86.9% above that low.
Does PMN stock pay dividends?
Promis Neurosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PMN?
Promis Neurosciences's Debt / Equity ratio is 0.